Literature DB >> 12056896

Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.

Fadi F Hamdan1, Stuart D C Ward, Nasir A Siddiqui, Lanh M Bloodworth, Jürgen Wess.   

Abstract

In this study, we employed an in situ disulfide cross-linking strategy to gain insight into the structure of the inactive and active state of the M(3) muscarinic acetylcholine receptor. Specifically, this study was designed to identify residues in TM I that are located in close to Cys532 (position 7.42), an endogenous cysteine residue present in the central portion of TM VII. Cysteine residues were substituted, one at a time, into 10 consecutive positions of TM I (Ala71-Val80) of a modified version of the M(3) muscarinic receptor that lacked most endogenous cysteine residues and contained a factor Xa cleavage site within the third intracellular loop. Following their expression in COS-7 cells, the 10 resulting cysteine mutant receptors were oxidized in their native membrane environment, either in the absence or in the presence of muscarinic ligands. Disulfide cross-link formation was monitored by examining changes in the electrophoretic mobility of oxidized and factor Xa-digested receptors on SDS gels. When molecular iodine was used as the oxidizing agent, the L77C receptor (position 1.42) was the only mutant receptor that displayed significant disulfide cross-linking, either in the absence or in the presence of muscarinic agonists or antagonists. On the other hand, when the Cu(II)-(1,10-phenanthroline)(3) complex served as the redox catalyst, muscarinic ligands inhibited disulfide cross-linking of the L77C receptor, probably because of impaired access of this relatively bulky oxidizing agent to the ligand binding crevice. The iodine cross-linking data suggest that M(3) muscarinic receptor activation is not associated with significant changes in the relative orientations of the outer and/or central segments of TM I and VII. In bovine rhodopsin, the residues present at the positions corresponding to Cys532 and Leu77 in the rat M(3) muscarinic receptor are not located directly adjacent to each other, raising the possibility that the relative orientations of TM I and VII are not identical among different class I GPCRs. Alternatively, dynamic protein backbone fluctuation may occur, enabling Cys532 to move within cross-linking distance of Leu77 (Cys77).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12056896     DOI: 10.1021/bi016029c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking.

Authors:  Oleg V Kovalenko; Xiuwei Yang; Tatiana V Kolesnikova; Martin E Hemler
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

2.  The leukocidin pore: evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis.

Authors:  Lakmal Jayasinghe; Hagan Bayley
Journal:  Protein Sci       Date:  2005-10       Impact factor: 6.725

Review 3.  Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.

Authors:  Patricia H Reggio
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

4.  Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.

Authors:  Soo-Kyung Kim; Zhan-Guo Gao; Lak Shin Jeong; Kenneth A Jacobson
Journal:  J Mol Graph Model       Date:  2006-05-09       Impact factor: 2.518

5.  Conformational changes in the parathyroid hormone receptor associated with activation by agonist.

Authors:  Beena E Thomas; Iwona Woznica; Dale F Mierke; Angela Wittelsberger; Michael Rosenblatt
Journal:  Mol Endocrinol       Date:  2008-02-07

Review 6.  Conformational changes involved in G-protein-coupled-receptor activation.

Authors:  Jürgen Wess; Sung-Jun Han; Soo-Kyung Kim; Kenneth A Jacobson; Jian Hua Li
Journal:  Trends Pharmacol Sci       Date:  2008-10-04       Impact factor: 14.819

7.  PTH and PTH antagonist induce different conformational changes in the PTHR1 receptor.

Authors:  Beena E Thomas; Sandhya Sharma; Dale F Mierke; Michael Rosenblatt
Journal:  J Bone Miner Res       Date:  2009-05       Impact factor: 6.741

8.  Structural organization and interactions of transmembrane domains in tetraspanin proteins.

Authors:  Oleg V Kovalenko; Douglas G Metcalf; William F DeGrado; Martin E Hemler
Journal:  BMC Struct Biol       Date:  2005-06-28

9.  CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why?

Authors:  Alison Grinthal; Guido Guidotti
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

10.  Structure modeling of all identified G protein-coupled receptors in the human genome.

Authors:  Yang Zhang; Mark E Devries; Jeffrey Skolnick
Journal:  PLoS Comput Biol       Date:  2006-02-17       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.